Last Updated: June 25, 2026

CLINICAL TRIALS PROFILE FOR SITAGLIPTIN HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for sitagliptin hydrochloride

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00087516 ↗	Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-06-01	The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00095056 ↗	An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-10-01	The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
NCT00103857 ↗	MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2005-03-17	The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for sitagliptin hydrochloride

Condition Name

Chart
Table

Condition Name for sitagliptin hydrochloride
Intervention	Trials
Type 2 Diabetes Mellitus	116
Diabetes Mellitus, Type 2	89
Type 2 Diabetes	73
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for sitagliptin hydrochloride
Intervention	Trials
Diabetes Mellitus, Type 2	307
Diabetes Mellitus	301
Diabetes Mellitus, Type 1	18
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for sitagliptin hydrochloride

Trials by Country

Map
Table

Trials by Country for sitagliptin hydrochloride
Location	Trials
Canada	107
India	91
China	90
Mexico	65
Germany	53
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for sitagliptin hydrochloride
Location	Trials
Texas	74
California	73
Florida	69
Ohio	52
New York	48
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for sitagliptin hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for sitagliptin hydrochloride
Clinical Trial Phase	Trials
PHASE4	6
PHASE3	5
PHASE2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for sitagliptin hydrochloride
Clinical Trial Phase	Trials
Completed	344
Unknown status	33
Terminated	30
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sitagliptin hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for sitagliptin hydrochloride
Sponsor	Trials
Merck Sharp & Dohme Corp.	125
Novo Nordisk A/S	18
Eli Lilly and Company	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for sitagliptin hydrochloride
Sponsor	Trials
Industry	319
Other	309
NIH	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.